Natural Products in Modulating Methamphetamine-Induced Neuronal Apoptosis

Natural Products in Modulating Methamphetamine-Induced Neuronal Apoptosis

Methamphetamine (METH), an amphetamine-type psychostimulant, is highly abused worldwide. Chronic abuse of METH causes neurodegenerative changes in central dopaminergic neurons with numerous neuropsychiatric consequences. Neuronal apoptosis plays a critical role in METH-induced neurotoxicity and may...

Full description

Bibliographic Details
Main Authors:	Yiwei Zeng, Yunhui Chen, Su Zhang, Huan Ren, Jialin Xia, Mengnan Liu, Baozhi Shan, Yulan Ren
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-01-01
Series:	Frontiers in Pharmacology
Subjects:	methamphetamine dopaminergic neurons apoptosis natural products neurodegenaration
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.805991/full

Similar Items

The Influence of Prenatal Exposure to Methamphetamine on the Development of Dopaminergic Neurons in the Ventral Midbrain
by: Walaa F. Alsanie, et al.
Published: (2023-03-01)

Molecular mechanisms of programmed cell death in methamphetamine-induced neuronal damage
by: Dongming Guo, et al.
Published: (2022-08-01)

Methamphetamine use : clinical and forensic aspects /
by: 411191 McPherson, Sandra B., et al.
Published: (2009)

Editorial: RNA binding proteins in neuroscience
by: Anca F. Savulescu, et al.
Published: (2023-12-01)

Neuron–Microglia Contact-Dependent Mechanisms Attenuate Methamphetamine-Induced Microglia Reactivity and Enhance Neuronal Plasticity
by: Joana Bravo, et al.
Published: (2022-01-01)

MiRNA-1976 Regulates the Apoptosis of Dopaminergic Neurons by Targeting the PINK1 Gene
by: Feng Qiu, et al.
Published: (2023-02-01)

Effects of Estrogen and Progesterone on Behavioral Impairment and Neuronal Death in Ovariectomized Rats Induced by Methamphetamine
by: Hossein Ghalehnoei, et al.
Published: (2020-07-01)

Effect of citronellol on oxidative stress, neuroinflammation and autophagy pathways in an in vivo model of Parkinson's disease
by: Richard L. Jayaraj, et al.
Published: (2022-11-01)

A functional characterisation of retrorubral field dopaminergic neurons
by: Bryden, LA
Published: (2021)

Olanzapine and its use for methamphetamine-induced psychosis
by: S. Nazir, et al.
Published: (2022-06-01)

Effects of berberine hydrochloride on methamphetamine-induced anxiety behaviors and relapse in rats
by: Leila Rezaeian, et al.
Published: (2020-11-01)

Prenatal and postnatal methamphetamine exposure alters prefrontal cortical gene expression and behavior in mice
by: Philip A. Adeniyi, et al.
Published: (2024-03-01)

Effects of Aerobic Exercise on Markers of Brain Injury in Methamphetamine-Dependent Individuals: A Randomized Controlled Trial
by: Zhicheng Zhu, et al.
Published: (2022-11-01)

Limonene, a Monoterpene, Mitigates Rotenone-Induced Dopaminergic Neurodegeneration by Modulating Neuroinflammation, Hippo Signaling and Apoptosis in Rats
by: Lujain Bader Eddin, et al.
Published: (2023-03-01)

Methamphetamine psychosis, the efficacy of atypical antipsychotics
by: Amir Rezaei Ardani, et al.
Published: (2015-01-01)

Reproductive status of male rat offspring following exposure to methamphetamine during intrauterine life: An experimental study
by: Zahra Khoshgoftar Some Saraii, et al.
Published: (2023-02-01)

Hypoplasia of dopaminergic neurons by hypoxia-induced neurotoxicity is associated with disrupted swimming development of larval zebrafish
by: Jong-Hyun Son, et al.
Published: (2022-09-01)

The Relationship between Iron and LRRK2 in a 6-OHDA-Induced Parkinson’s Disease Model
by: Ruru Jia, et al.
Published: (2023-02-01)

The Effects of Prenatal Exposure to Pregabalin on the Development of Ventral Midbrain Dopaminergic Neurons
by: Walaa F. Alsanie, et al.
Published: (2022-03-01)

Common gray matter loss in the frontal cortex in patients with methamphetamine-associated psychosis and schizophrenia
by: Xiaojian Jia, et al.
Published: (2022-01-01)

Metabolic Profile Variations along the Differentiation of Human-Induced Pluripotent Stem Cells to Dopaminergic Neurons
by: Emma Veronica Carsana, et al.
Published: (2022-08-01)

PPAR-gamma agonist pioglitazone recovers mitochondrial quality control in fibroblasts from PITRM1-deficient patients
by: Alessia Di Donfrancesco, et al.
Published: (2023-07-01)

The Fault in Our Astrocytes - cause or casualties of proteinopathies of ALS/FTD and other neurodegenerative diseases?
by: Lynette M. Bustos, et al.
Published: (2023-02-01)

The Response of Ventral Tegmental Area Dopaminergic Neurons to Bupropion: Excitation or Inhibition?
by: Shirin Sadighparvar, et al.
Published: (2019-07-01)

Celastrol Inhibits Dopaminergic Neuronal Death of Parkinson’s Disease through Activating Mitophagy
by: Ming-Wei Lin, et al.
Published: (2019-12-01)

Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson’s Disease
by: Ramesh Pariyar, et al.
Published: (2022-02-01)

Aromatic-Turmerone Analogs Protect Dopaminergic Neurons in Midbrain Slice Cultures through Their Neuroprotective Activities
by: Yuria Hori, et al.
Published: (2021-05-01)

Mitochondrial Phenotypes in Parkinson’s Diseases—A Focus on Human iPSC-Derived Dopaminergic Neurons
by: Leonie M. Heger, et al.
Published: (2021-12-01)

Batryticatus Bombyx Protects Dopaminergic Neurons Against MPTP-Induced Neurotoxicity by Inhibiting Oxidative Damage
by: Hye-Sun Lim, et al.
Published: (2019-11-01)

Identification of Potential Biomarkers for Diagnosis of Patients with Methamphetamine Use Disorder
by: Won-Jun Jang, et al.
Published: (2023-05-01)

Effect of risperidone on the cravings of patients with methamphetamine use disorder
by: N. Hassan, et al.
Published: (2022-06-01)

The Influence of Prenatal Exposure to Quetiapine Fumarate on the Development of Dopaminergic Neurons in the Ventral Midbrain of Mouse Embryos
by: Walaa F. Alsanie, et al.
Published: (2022-10-01)

Cistanche tubulosa Protects Dopaminergic Neurons through Regulation of Appotosis and Glial Cell-derived Neurotrophic Factor: in Vivo and in Vitro
by: Qian Xu, et al.
Published: (2016-12-01)

Key roles of autophagosome/endosome maturation mediated by Syntaxin17 in methamphetamine-induced neuronal damage in mice
by: Xi Wang, et al.
Published: (2024-01-01)

Regulation and bioinformatic analysis of circ_0015891/miR-129-1-3p axis in methamphetamine-induced dopaminergic apoptosis
by: Bingpeng Deng, et al.
Published: (2022-09-01)

Prolonged Differentiation of Neuron-Astrocyte Co-Cultures Results in Emergence of Dopaminergic Neurons
by: Victoria C. de Leeuw, et al.
Published: (2023-02-01)

Genetic inactivation of alpha-synuclein affects embryonic development of dopaminergic neurons of the substantia nigra, but not the ventral tegmental area, in mouse brain
by: Tatiana V. Tarasova, et al.
Published: (2018-05-01)

Evaluating the impact of an emergency department protocol that guides management of methamphetamine-induced agitation and psychosis
by: Julie Nguyen, PharmD, et al.
Published: (2022-01-01)

Executive Functions in Methamphetamine and Heroin Users versus Non-Users
by: Mehrdad Salehi, et al.
Published: (2013-11-01)

Lactoferrin Protects against Methamphetamine Toxicity by Modulating Autophagy and Mitochondrial Status
by: Larisa Ryskalin, et al.
Published: (2021-09-01)